Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma

Intratumoral bacteria interact with metabolites and genetic alterations in hepatocellular carcinoma

Bibliographic Details
Main Authors:	Chen Xue, Junjun Jia, Xinyu Gu, Lin Zhou, Juan Lu, Qiuxian Zheng, Yuanshuai Su, Shusen Zheng, Lanjuan Li
Format:	Article
Language:	English
Published:	Nature Publishing Group 2022-09-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-022-01159-9

Similar Items

The interaction between intratumoral bacteria and metabolic distortion in hepatocellular carcinoma
by: Chen Xue, et al.
Published: (2024-03-01)

Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes
by: Chen Xue, et al.
Published: (2022-10-01)

ALYREF mediates RNA m5C modification to promote hepatocellular carcinoma progression
by: Chen Xue, et al.
Published: (2023-03-01)

Integrated bioinformatics analysis reveals the function and prognostic value of OSBPL3 in hepatocellular carcinoma
by: Yuanshuai Su, et al.
Published: (2023-06-01)

Functions and underlying mechanisms of miR-650 in human cancers
by: Yuanshuai Su, et al.
Published: (2022-03-01)

Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma
by: Yuanshuai Su, et al.
Published: (2023-05-01)

The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma
by: Jian-Hang Huang, et al.
Published: (2022-10-01)

Intratumor Mycoplasma promotes the initiation and progression of hepatocellular carcinoma
by: Kailiang Qiao, et al.
Published: (2023-12-01)

Effects of 3‐HAA on HCC by Regulating the Heterogeneous Macrophages—A scRNA‐Seq Analysis
by: Chen Xue, et al.
Published: (2023-06-01)

Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
by: Sharanya Maanasi Kalasekar, et al.
Published: (2021-11-01)

Health and Disease: Akkermansia muciniphila, the Shining Star of the Gut Flora
by: Chen Xue, et al.
Published: (2023-01-01)

Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis
by: Yi Wang, et al.
Published: (2023-10-01)

Intratumor Regulatory Noncytotoxic NK Cells in Patients with Hepatocellular Carcinoma
by: Alessandra Zecca, et al.
Published: (2021-03-01)

Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma
by: Fei-Qi Xu, et al.
Published: (2023-01-01)

Intratumoral perfusion may affect microwave ablation area of hepatocellular carcinoma
by: Fubo Zhou, et al.
Published: (2023-12-01)

The crosstalk of intratumor bacteria and the tumor
by: Jiating Huang, et al.
Published: (2024-01-01)

A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genes
by: Qingmiao Shi, et al.
Published: (2023-06-01)

Identification of intratumor bacteria-associated prognostic risk score in adrenocortical carcinoma
by: Linyi Tan, et al.
Published: (2024-04-01)

Establishment and Validation of a Novel Risk Score for Hepatocellular Carcinoma Based on Bile Acid and Bile Salt Metabolism-Related Genes
by: Qingmiao Shi, et al.
Published: (2023-05-01)

Multiparametric MRI-based intratumoral and peritumoral radiomics for predicting the pathological differentiation of hepatocellular carcinoma
by: Hai-Feng Liu, et al.
Published: (2024-03-01)

Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma
by: Wei Jia, et al.
Published: (2020-08-01)

Nanosecond pulse effectively ablated hepatocellular carcinoma with alterations in the gut microbiome and serum metabolites
by: Yawen Zou, et al.
Published: (2023-05-01)

Transcriptome analysis revealed key prognostic genes and microRNAs in hepatocellular carcinoma
by: Xi Ma, et al.
Published: (2020-04-01)

The enrichment of the gut microbiota Lachnoclostridium is associated with the presence of intratumoral tertiary lymphoid structures in hepatocellular carcinoma
by: Rui Zhao, et al.
Published: (2023-12-01)

Intratumoral PPT1-positive macrophages determine immunosuppressive contexture and immunotherapy response in hepatocellular carcinoma
by: Qiang Zhou, et al.
Published: (2023-06-01)

Intratumoral microorganisms in tumors of the digestive system
by: Mengjuan Xuan, et al.
Published: (2024-01-01)

Inhibiting PLA2G7 reverses the immunosuppressive function of intratumoral macrophages and augments immunotherapy response in hepatocellular carcinoma
by: Feng Zhang, et al.
Published: (2024-01-01)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
by: Qianwei Ye, et al.
Published: (2019-07-01)

Renal Cell Carcinoma With Intratumoral Pseudoaneurysm
by: Daniel P. Pierce, et al.
Published: (2022-11-01)

Intratumoral bacteria in uveal melanoma: A case report
by: Katherine Vega Escobar, et al.
Published: (2023-06-01)

Awareness of intratumoral bacteria and their potential application in cancer treatment
by: Yin Liang, et al.
Published: (2023-05-01)

Significance of <i>TERT</i> Genetic Alterations and Telomere Length in Hepatocellular Carcinoma
by: Jeong-Won Jang, et al.
Published: (2021-04-01)

Tryptophan 2,3-dioxygenase expression identified in human hepatocellular carcinoma cells and in intratumoral pericytes of most cancers
by: Hoffmann, D, et al.
Published: (2019)

Atezolizumab plus bevacizumab-induced intratumoral hemorrhage in a patient with rib metastasis from unresectable hepatocellular carcinoma
by: Yasuhito Mitsuyama, MD, et al.
Published: (2023-09-01)

Metabolomic biomarkers for the diagnosis and post-transplant outcomes of AFP negative hepatocellular carcinoma
by: Zuyuan Lin, et al.
Published: (2023-02-01)

Intratumoral bacteria may elicit chemoresistance by metabolizing anticancer agents
by: Leore T. Geller, et al.
Published: (2018-01-01)

Integrated genetic and epigenetic analysis reveals DNA repair alterations in multifocal hepatocellular carcinoma
by: Yi-Hong Ling, et al.
Published: (2023-06-01)

Intratumoral and peritumoral radiomics based on contrast-enhanced MRI for preoperatively predicting treatment response of transarterial chemoembolization in hepatocellular carcinoma
by: Ying Zhao, et al.
Published: (2023-10-01)

Intratumor heterogeneity alters most effective drugs in designed combinations
by: Zhao, Boyang, et al.
Published: (2015)

Genetic Predisposition to Hepatocellular Carcinoma
by: Rosa M. Pascale, et al.
Published: (2022-12-01)